These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 29906298)
1. Synthesis, COX-1/2 inhibition and antioxidant activities of new oxicam analogues designed as potential chemopreventive agents. Szczęśniak-Sięga B; Gębczak K; Gębarowski T; Maniewska J Acta Biochim Pol; 2018; 65(2):199-207. PubMed ID: 29906298 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation as well as in silico studies of arylpiperazine-1,2-benzothiazine derivatives as novel anti-inflammatory agents. Szczęśniak-Sięga BM; Wiatrak B; Czyżnikowska Ż; Janczak J; Wiglusz RJ; Maniewska J Bioorg Chem; 2021 Jan; 106():104476. PubMed ID: 33250206 [TBL] [Abstract][Full Text] [Related]
3. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network. Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867 [TBL] [Abstract][Full Text] [Related]
4. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond. Xu S; Rouzer CA; Marnett LJ IUBMB Life; 2014 Dec; 66(12):803-11. PubMed ID: 25537198 [TBL] [Abstract][Full Text] [Related]
5. Biological Evaluation and Molecular Docking Studies of Novel 1,3,4-Oxadiazole Derivatives of 4,6-Dimethyl-2-sulfanylpyridine-3-carboxamide. Świątek P; Glomb T; Dobosz A; Gębarowski T; Wojtkowiak K; Jezierska A; Panek JJ; Świątek M; Strzelecka M Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008977 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and antioxidant properties of a novel resveratrol-salicylate hybrid analog. Aldawsari FS; Aguiar RP; Wiirzler LA; Aguayo-Ortiz R; Aljuhani N; Cuman RK; Medina-Franco JL; Siraki AG; Velázquez-Martínez CA Bioorg Med Chem Lett; 2016 Mar; 26(5):1411-5. PubMed ID: 26850006 [TBL] [Abstract][Full Text] [Related]
7. Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity. Lazer ES; Miao CK; Cywin CL; Sorcek R; Wong HC; Meng Z; Potocki I; Hoermann M; Snow RJ; Tschantz MA; Kelly TA; McNeil DW; Coutts SJ; Churchill L; Graham AG; David E; Grob PM; Engel W; Meier H; Trummlitz G J Med Chem; 1997 Mar; 40(6):980-9. PubMed ID: 9083488 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs. Thomas K; Moody TW; Jensen RT; Tong J; Rayner CL; Barnett NL; Fairfull-Smith KE; Ridnour LA; Wink DA; Bottle SE Eur J Med Chem; 2018 Mar; 147():34-47. PubMed ID: 29421569 [TBL] [Abstract][Full Text] [Related]
9. [Possibilities of individual choice of NSAIDs on the example of the oxicam class, taking into account clinical and pharmacological characteristics]. Putilina MV; Teplova NV Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):36-41. PubMed ID: 35904290 [TBL] [Abstract][Full Text] [Related]
10. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template. Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869 [TBL] [Abstract][Full Text] [Related]
11. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os. Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061 [TBL] [Abstract][Full Text] [Related]
12. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences. Chakraborty S; Bose M; Sarkar M Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609 [TBL] [Abstract][Full Text] [Related]
13. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs. Chakraborty H; Roy S; Sarkar M Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046 [TBL] [Abstract][Full Text] [Related]
14. Scavenging of photogenerated ROS by Oxicams. Possible biological and environmental implications. Ferrari GV; Natera J; Paulina Montaña M; Muñoz V; Gutiérrez EL; Massad W; Miskoski S; García NA J Photochem Photobiol B; 2015 Dec; 153():233-9. PubMed ID: 26453988 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile. Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity. Arisawa M; Kasaya Y; Obata T; Sasaki T; Nakamura T; Araki T; Yamamoto K; Sasaki A; Yamano A; Ito M; Abe H; Ito Y; Shuto S J Med Chem; 2012 Sep; 55(18):8152-63. PubMed ID: 22916727 [TBL] [Abstract][Full Text] [Related]
17. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion. Mondal Roy S; Sarkar M Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Zebardast T; Zarghi A; Daraie B; Hedayati M; Dadrass OG Bioorg Med Chem Lett; 2009 Jun; 19(12):3162-5. PubMed ID: 19447036 [TBL] [Abstract][Full Text] [Related]
19. Meloxicam inhibits fipronil-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells. Park JH; Park YS; Lee JB; Park KH; Paik MK; Jeong M; Koh HC J Appl Toxicol; 2016 Jan; 36(1):10-23. PubMed ID: 25772694 [TBL] [Abstract][Full Text] [Related]
20. In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from the oxicam and sulfoanilide families. Van Antwerpen P; Nève J Eur J Pharmacol; 2004 Aug; 496(1-3):55-61. PubMed ID: 15288575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]